PortfoliosLab logo

Aprea Therapeutics, Inc. (APRE)

Equity · Currency in USD · Last updated Nov 28, 2022

Company Info

ISINUS03836J1025
CUSIP03836J102
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.39
Year Range$0.35 - $4.24
EMA (50)$0.62
EMA (200)$1.39
Average Volume$122.41K
Market Capitalization$20.67M

APREShare Price Chart


Loading data...

APREPerformance

The chart shows the growth of $10,000 invested in Aprea Therapeutics, Inc. in Oct 2019 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $188 for a total return of roughly -98.12%. All prices are adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%JuneJulyAugustSeptemberOctoberNovember
-54.03%
-2.57%
APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

APRECompare to other instruments

Search for stocks, ETFs, and funds to compare with APRE

APREReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-45.00%4.33%
6M-52.17%-0.78%
YTD-86.59%-15.53%
1Y-91.05%-14.36%
5Y-71.72%10.86%
10Y-71.72%10.86%

APREMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-27.18%-16.75%6.90%-21.51%-42.60%-10.50%28.00%-17.29%-18.14%3.08%-42.54%
202112.20%9.24%-15.42%-8.04%-10.02%15.64%-13.32%9.22%10.61%-3.13%-18.38%-28.96%
2020-16.45%-10.54%1.34%-8.54%-15.51%44.38%-29.27%-1.20%-11.22%-9.35%15.73%-80.51%
201917.80%4.27%82.25%

APRESharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aprea Therapeutics, Inc. Sharpe ratio is -0.99. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.200.00JuneJulyAugustSeptemberOctoberNovember
-0.99
-0.60
APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

APREDividend History


Aprea Therapeutics, Inc. doesn't pay dividends

APREDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-99.22%
-16.06%
APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)

APREWorst Drawdowns

The table below shows the maximum drawdowns of the Aprea Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aprea Therapeutics, Inc. is 99.29%, recorded on Nov 22, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.29%Dec 30, 2019732Nov 22, 2022
-24.77%Nov 20, 20195Nov 26, 20199Dec 10, 201914
-17.45%Dec 13, 20194Dec 18, 20194Dec 24, 20198
-8.92%Oct 22, 20197Oct 30, 201911Nov 14, 201918
-7.61%Oct 4, 20193Oct 8, 20198Oct 18, 201911
-0.9%Nov 18, 20191Nov 18, 20191Nov 19, 20192

APREVolatility Chart

Current Aprea Therapeutics, Inc. volatility is 90.23%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%JuneJulyAugustSeptemberOctoberNovember
90.23%
12.31%
APRE (Aprea Therapeutics, Inc.)
Benchmark (^GSPC)